Skip to main navigation Skip to search Skip to main content

A Phase 1, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study of SQZ-PBMC-HPV asMonotherapy and in Combination with Atezolizumab or Other Immune Checkpoint Inhibitors in HLA-A*02+Patients with HPV16+ Recurrent, Locally Advanced or Metast

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology